Download Files:
Emicerfont
SKU
HY-14367-1 mg
Category Reference compound
Tags CRFR, GPCR/G Protein, Neurological Disease; Endocrinology
$200 – $5,200
Products Details
Product Description
– Emicerfont is a corticotropin-releasing factor type 1 (CRF1) receptor antagonist with an IC50 of 66 nM.
Web ID
– HY-14367
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture and light)
Shipping
– Room Temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C22H24N6O2
References
– [1]Zorrilla EP, et al. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend. 2013 Mar 1;128(3):175-86.
CAS Number
– 786701-13-1
Molecular Weight
– 404.46
Compound Purity
– 98.03
SMILES
– CC1=CC(OC)=CC=C1N(CC2)C3=C2C(N4C=CC(N5CCN([H])C5=O)=N4)=CC(C)=N3
Clinical Information
– Phase 2
Research Area
– Neurological Disease; Endocrinology
Solubility
– DCM : ≥ 16.67 mg/mL
Target
– CRFR
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.